Close
ACHEMA MIDDLE EAST 2026

New Approach To Gene Editing For Improved Cancer Treatment

A novel approach within the genetic engineering of cells promises major enhancements when it comes to speed, effectiveness, and reduction in cellular toxicity as...

Report Predicts OSD Contract Manufacturing Market Growth

For many years, the rising complexity of APIs has led to the development of a sea of novel formulations that help in the efficient...

Driving Factors Behind Digital Bioprocessing Market Growth

One of the market reports has gone on to show that the digital biomanufacturing segment is expected to grow at a CAGR of 11%...

FDA Draft Guidance Supports Decentralized Clinical Trials

US Food and Drug Administration has come up with a novel draft guidance in order to further support the use of decentralised clinical trials...

Pharma Industry Groups Criticise Proposed EU Drug Regulation

The EU's drug regulations can get a major makeover soon. In a set of proposals, the European Commission looks to address numerous shortfalls troubling...

Phase I Trial of The South Korean DuoChol Vaccine In Sweden

The South Korea-based International Vaccine Institute- IVI has gone ahead with the clinical manufacturing of DuoChol, a new low-cost oral vaccine for cholera in...

EU Drug Manufacturing Law Changes Disappoint Manufacturers

The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws. The changes have...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...